Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study.
AuteursAlsoud D, Sabino J, Franchimont D, Cremer A, Busschaert J, D'Heygere F, Bossuyt P, Vijverman A, Vermeire S, Ferrante M
Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study.
AuteursAlsoud D, Sabino J, Franchimont D, Cremer A, Busschaert J, D'Heygere F, Bossuyt P, Vijverman A, Vermeire S, Ferrante M
The Utilisation of Digital Applications for Measuring Patient Outcomes Following Bariatric Surgery: a Systematic Review and Meta-analysis of Comparative Studies.
AuteursFarinella E, Koliakos N, Papakonstantinou D, Breuer N, Pau L, Poras M, Maréchal MT, Briganti G